Artificial heart valves must remain durable and biocompatible throughout years of continuous operation. One of the most critical long-term risks is calcification — the deposition of calcium salts on valve leaflets and supporting structures. Calcification can impair valve flexibility, increase regurgitation, and ultimately lead to device failure. Rigorous testing is therefore essential to validate valve durability and patient safety.
At our laboratory, we conduct calcification testing under internationally recognized protocols, providing manufacturers with the data needed to demonstrate reliability and compliance.